December 9-13, 2014 (abstr S3-01)
Lips EH,
et al.
generation sequencing of triple negative breast cancer to find predictors for chemotherapy
response. Breast Cancer Res. 2015 Oct 3;17(1):134.
von Minckwitz G,
et al.
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast
cancer (GeparSixto; GBG 66): a randomised phase 2 trial. Lancet Oncol. 2014 Jun;15(7):747-56.
